BIOMAT Database Logo BIOMAT Database Logo

Heterogeneity of mutations in Bulgarian phenylketonuria haplotype 1 and 4 alleles. 1992

L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Laboratory of Molecular Pathology, Medical Academy, Sofia, Bulgaria.

A study of Bulgarian patients with classical PKU demonstrated that haplotypes 1 and 4 carry a significant number of rare molecular defects resulting from independent mutational events. Differences in mutations associated with these common haplotypes exist even between populations which share a common major PKU mutation. Some amino acid substitutions, previously reported to lead to mild phenylalanine hydroxylase deficiency, were detected in the present study in compound heterozygotes with severe PKU. These findings preclude carrier testing and hyperphenylalaninemia typing by genomic analysis at least in the heterogeneous Bulgarian population.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D002031 Bulgaria A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. The capital is Sofia.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA

Related Publications

L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Haplotype analysis of phenylalanine hydroxylase alleles in polish families with phenylketonuria.
January 1989, Acta biochimica Polonica,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Phenylketonuria: detection of a frequent haplotype 4 allele mutation.
December 1989, Human genetics,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Phenylketonuria in Poland: 66% of PKU alleles are caused by three mutations.
November 1991, Human genetics,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
[DNA analysis in classic phenylketonuria--screening for mutations and haplotype analysis in Slovak families].
April 1994, Bratislavske lekarske listy,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
[Genetical heterogeneity of phenylketonuria].
January 1982, Voprosy meditsinskoi khimii,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Association between mutations and the variable number tandem repeat alleles in a sample of Turkish phenylketonuria patients.
January 1994, Journal of inherited metabolic disease,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.
August 1991, Human genetics,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Prenatal diagnosis of phenylketonuria by haplotype analysis.
June 1989, Prenatal diagnosis,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Phenylketonuria mutations in Germany.
May 1999, Human genetics,
L Kalaydjieva, and B Dworniczak, and I Kremensky, and K Koprivarova, and B Radeva, and R Milusheva, and C Aulehla-Scholz, and J Horst
Phenylketonuria mutations in Europe.
April 2003, Human mutation,
Copied contents to your clipboard!